• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients.

作者信息

Nobile M T, Canobbio L, Sobrero A, Galligioni E, Vidili M G, Fassio T, Lo Re G, Rubagotti A, Sertoli M R, Rosso R

机构信息

Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.

出版信息

Adv Exp Med Biol. 1988;244:213-8. doi: 10.1007/978-1-4684-5607-3_22.

DOI:10.1007/978-1-4684-5607-3_22
PMID:3073656
Abstract
摘要

相似文献

1
A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients.一项针对未经治疗的晚期结直肠癌患者，比较单纯使用5-氟尿嘧啶与5-氟尿嘧啶联合高剂量亚叶酸钙的随机试验。
Adv Exp Med Biol. 1988;244:213-8. doi: 10.1007/978-1-4684-5607-3_22.
2
Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trial.
Cancer. 1995 Mar 15;75(6):1238-44. doi: 10.1002/1097-0142(19950315)75:6<1238::aid-cncr2820750605>3.0.co;2-p.
3
[Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].伊立替康联合氟尿嘧啶和亚叶酸钙治疗晚期结直肠癌
Nihon Rinsho. 2003 Sep;61 Suppl 7:360-3.
4
Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.钇90微球联合氟尿嘧啶/亚叶酸钙化疗与单纯氟尿嘧啶/亚叶酸钙化疗治疗晚期结直肠癌的随机2期试验
J Surg Oncol. 2004 Nov 1;88(2):78-85. doi: 10.1002/jso.20141.
5
A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.一项针对既往未经治疗的晚期结直肠癌患者，比较5-氟尿嘧啶、5-氟尿嘧啶与高剂量亚叶酸钙、5-氟尿嘧啶与甲氨蝶呤疗效的前瞻性随机试验。
J Clin Oncol. 1987 Oct;5(10):1559-65. doi: 10.1200/JCO.1987.5.10.1559.
6
Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.晚期结直肠癌中高剂量亚叶酸钙每周给药与低剂量亚叶酸钙联合氟尿嘧啶的比较：一项随机多中心试验的结果。转移性结直肠癌姑息治疗研究组研究方案1
J Clin Oncol. 1996 Aug;14(8):2274-9. doi: 10.1200/JCO.1996.14.8.2274.
7
Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.晚期癌症治疗中的生化调节：亚叶酸钙、氟尿嘧啶和碘脱氧尿苷联合应用的研究
Clin Cancer Res. 1996 Sep;2(9):1475-80.
8
5-Fluorouracil and low-dose leucovorin in metastatic colorectal cancer: a pilot study.5-氟尿嘧啶与低剂量亚叶酸在转移性结直肠癌中的应用：一项试点研究。
Cancer Chemother Pharmacol. 1995;35(5):437-40. doi: 10.1007/s002800050259.
9
Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.奥沙利铂联合羟基喜树碱与奥沙利铂联合5-氟尿嘧啶和亚叶酸钙治疗晚期结直肠癌的疗效比较
Chin Med J (Engl). 2006 Nov 5;119(21):1829-33.
10
Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.伊立替康联合推注5-氟尿嘧啶和左亚叶酸钙方案治疗日本转移性结直肠癌患者的疗效和安全性：日本一家机构的经验
Jpn J Clin Oncol. 2007 Sep;37(9):686-91. doi: 10.1093/jjco/hym091. Epub 2007 Aug 24.

引用本文的文献

1
Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administration.高剂量亚叶酸钙和干扰素α-2b对晚期结直肠癌患者5-氟尿嘧啶的双重调节作用：每周给药的I期和II期研究
J Cancer Res Clin Oncol. 1994;120(5):314-8. doi: 10.1007/BF01236390.
2
Continuous infusion of 5-fluorouracil with alpha 2b interferon for advanced colorectal carcinoma.5-氟尿嘧啶与α2b干扰素持续输注治疗晚期结直肠癌。
Br J Cancer. 1995 Jul;72(1):193-7. doi: 10.1038/bjc.1995.302.